Emcure has consistently been at the forefront of pharmaceutical innovation, and our awards underscore our expertise in diverse therapeutic areas

Recognized as a
LEADER IN
SEVERAL
BIOLOGICS

and complex generic APIs.

Celebrated for
introducing first-to-market
formulations like Troxipide
and Ferric Carboxymaltose.

Silver Impact Award

Category

Vylda

Platform

Pronto Consult Awards

Year

2022

1ˢᵗ Runner Up

Category

New Introduction of
the Year (Chronic) – Dydrofem

Platform

AWACS
Pharmarack Awards

Year

2022

Golden Impact Award

Category

Ferium 500 Inj.

Platform

Pronto Consult
Consumer Awards

Year

2021

Platinum Impact Award

Category

Vylda

Platform

Pronto Consult
Consumer Awards

Year

2020

Bronze Award

Category

Brand of the Year
(Chronic/Subchronic) – Orofer XT

Platform

AWACS Awards in
Marketing Excellence

Year

2019

Gold Award

Category

New Introduction of the Year
(Chronic/Subchronic) – Emluz

Platform

AWACS Awards in
Marketing Excellence

Year

2018

Gold Award

Category

Brand of the Year
(Chronic/Subchronic)- Orofer XT

Platform

AWACS Awards in
Marketing Excellence

Year

2018

Silver Award

Category

New Introduction of the Year
(Chronic/Subchronic) – Instgra

Platform

AWACS Awards in
Marketing Excellence

Year

2018

A TESTAMENT TO QUALITY AND IMPACT

Each award is a milestone in our journey to redefine healthcare. These recognitions inspire us to deliver innovative solutions for patients’ evolving needs worldwide.